Otolaryngology Doctors in Lancaster, PA Accepting Medicare
7 Otolaryngology doctors found. Showing 1 - 7
 Dr. Francis P Ruggiero, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2160 Noll Dr Ste 200, Lancaster, PA 17603 Phone: 717-481-8720 Fax: 717-481-8726 |
Dr. Daryl George Bodner, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 |
Dr. Victor Manuel Da Costa, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1430 Harrisburg Pike, Lancaster, PA 17601 Phone: 800-243-1455 Fax: 717-606-1124 |
Dr. Steven Nolan Dorf, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 |
Dr. John W Miller Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 |
Dr. Joseph Stephen Annese, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 810 Plaza Blvd, Lancaster, PA 17601 Phone: 717-394-5088 Fax: 717-394-5590 |
 Dr. Karen A. Rizzo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 930 Red Rose Ct, Suite 301, Lancaster, PA 17601 Phone: 717-517-9083 Fax: 717-517-9243 |
News Archive
Added benefit of aflibercept not proven in myopic choroidal neovascularisation
Aflibercept (trade name: Eylea) has been approved since October 2015 for adults with impaired vision due to myopic choroidal neovascularisation.
Studies evaluate ovarian cancer surgery outcomes and clinical standards
These studies were supported financially by the Medtronic Chair in Surgical Training and Research and a research grant from the Carlos III-FEDER Institute of Health.
Most comprehensive genome-wide experimental analyses of sense-antisense transcripts to date
A team of scientists led by Dr. Kuniya Abe from the RIKEN BioResource Center in Japan has performed one of the most comprehensive genome-wide experimental analyses of sense-antisense transcripts to date. Their findings are published in the April issue of the journal Genome Research.
InfraReDx TVC Imaging System to be exhibited at TCT 2011
InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that its TVC Imaging System for the true vessel characterization of coronary artery disease will be highlighted during the annual Transcatheter Cardiovascular Therapeutics Meeting (TCT 2011).
› Verified 6 days ago
Internal Medicine
Family Medicine
Psychiatry & Neurology
Pediatrics
Orthopaedic Surgery
Anesthesiology
Radiology
Surgery
Obstetrics & Gynecology
Ophthalmology